Indivior PLC (INDV)
INDV moved a median of +0.10% 30 minutes after news, and -0.08% by the close. How INDV actually reacts to news — the realized, point-in-time move the market made, measured across 938 labeled events over the last three years with zero look-ahead.
INDV’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 48% | 928 |
| 30-min | +0.10% | 52% | 936 |
| 60-min | +0.08% | 53% | 937 |
| to close | -0.08% | 49% | 936 |
| Middle 50% of INDV reactions | -0.57% to +0.65% |
|---|---|
| Median reaction (30-min) | +0.10% |
| Measured reactions | 938 |
Half of all Indivior PLC news events land between -0.57% and +0.65% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How INDV reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 11 | +0.63% | 64% | +0.10% |
| Coverage initiations | 16 | -0.43% | 19% | 0.00% |
| Rating reiterations | 24 | -0.45% | 33% | -0.48% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 3 further classes were observed with fewer than 10 measured events and are not published. See how INDV ranks against every other measured name →
That’s how INDV usually reacts — get an email when it moves on news →Email me when INDV moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to INDV's baseline. Nothing else.
Recent INDV events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K Indivior Pharmaceuticals For: Oct 15 | SEC filing · Form 8-K | SEC EDGAR | +0.42% | -3.05% | |
| Form 8-K Indivior Pharmaceuticals For: Oct 06 | SEC filing · Form 8-K | SEC EDGAR | -0.04% | -0.17% | |
| Form 8-K Indivior Pharmaceuticals For: Sep 16 | SEC filing · Form 8-K | SEC EDGAR | +0.60% | +2.67% | |
| Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend | Press release | GlobeNewswire | +0.60% | +2.67% | |
| Form 8-K Indivior Pharmaceuticals For: Sep 09 | SEC filing · Form 8-K | SEC EDGAR | +1.44% | +1.12% | |
| Form EFFECT Indivior Pharmaceuticals | SEC filing · Form EFFECT | SEC EDGAR | -0.40% | -0.78% | |
| Form S-4/A Indivior Pharmaceuticals | SEC filing · Form S-4 | SEC EDGAR | -0.26% | -0.20% | |
| Halper Sadeh LLC is Investigating Whether INDV, FHB, BGMS are Obtaining Fair Deals for their Shareholders | Press release | GlobeNewswire | +0.03% | -0.43% | |
| INDV Stock Alert: Halper Sadeh LLC is Investigating Whether Indivior Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders | Press release | Business Wire | +0.12% | +0.17% | |
| Form S-4 Indivior Pharmaceuticals | SEC filing · Form S-4 | SEC EDGAR | +0.12% | +0.17% | |
| Form 10-Q Indivior Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -3.11% | -3.79% | |
| Form 8-K Indivior Pharmaceuticals For: Aug 01 | SEC filing · Form 8-K | SEC EDGAR | -0.38% | -5.99% | |
| Form 8-K Indivior Pharmaceuticals For: Aug 03 | SEC filing · Form 8-K | SEC EDGAR | -0.38% | -5.99% | |
| Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance | Press release | GlobeNewswire | -0.38% | -5.99% | |
| INDV Stock Alert: Halper Sadeh LLC is Investigating Whether Indivior Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders | Press release | Business Wire | +0.76% | -0.63% | |
| Indivior to Report Second Quarter 2026 Financial Results and Host Webcast | Press release | GlobeNewswire | +0.50% | +1.15% | |
| New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization | Press release | GlobeNewswire | +1.33% | +0.72% | |
| Form 8-K Indivior Pharmaceuticals For: May 13 | SEC filing · Form 8-K | SEC EDGAR | -0.79% | -1.03% | |
| Indivior to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | -1.02% | -1.87% | |
| Form 8-K Indivior Pharmaceuticals For: May 04 | SEC filing · Form 8-K | SEC EDGAR | +0.10% | +0.03% | |
| Indivior Announces $175 Million Accelerated Share Repurchase | Press release | GlobeNewswire | +0.10% | +0.03% | |
| Form 10-Q Indivior Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +6.08% | +0.72% | |
| Form 8-K Indivior Pharmaceuticals For: Apr 30 | SEC filing · Form 8-K | SEC EDGAR | +1.31% | +2.25% | |
| Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance | Press release | GlobeNewswire | +1.31% | +2.25% | |
| Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder | Press release | GlobeNewswire | +0.18% | +1.22% | |
| Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse | Press release | GlobeNewswire | -0.08% | -1.38% | |
| Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th | Press release | GlobeNewswire | +0.65% | +1.64% | |
| New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities | Press release | GlobeNewswire | +0.69% | +4.89% | |
| Form ARS Indivior Pharmaceuticals For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -0.87% | -2.69% | |
| Form DEF 14A Indivior Pharmaceuticals For: May 13 | SEC filing · Form DEF | SEC EDGAR | -0.87% | -2.69% | |
| Form DEFA14A Indivior Pharmaceuticals | SEC filing · Form DEFA14A | SEC EDGAR | -0.87% | -2.69% | |
| Form 8-K Indivior Pharmaceuticals For: Mar 17 | SEC filing · Form 8-K | SEC EDGAR | +1.61% | -2.33% | |
| National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder | Press release | GlobeNewswire | -0.61% | +0.35% | |
| Form 8-K Indivior Pharmaceuticals For: Mar 12 | SEC filing · Form 8-K | SEC EDGAR | +1.19% | +0.42% | |
| Form 8-K Indivior Pharmaceuticals For: Mar 12 | SEC filing · Form 8-K | SEC EDGAR | +2.13% | +3.59% | |
| Indivior Announces Proposed Convertible Senior Notes Offering | Press release | GlobeNewswire | +2.13% | +3.59% | |
| Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering | Press release | GlobeNewswire | +1.19% | +0.42% | |
| New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder | Press release | GlobeNewswire | -0.48% | -0.46% | |
| Form 10-K Indivior Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.21% | -1.30% | |
| Form 8-K Indivior Pharmaceuticals For: Feb 26 | SEC filing · Form 8-K | SEC EDGAR | +0.81% | -2.18% | |
| Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results | Press release | GlobeNewswire | +0.81% | -2.18% | |
| Indivior to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | -1.35% | -0.42% | |
| Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26?? | Press release | GlobeNewswire | +0.52% | +0.75% | |
| Form 15-12G Indivior Pharmaceuticals | SEC filing · Form 15-12G | SEC EDGAR | +0.36% | +3.45% | |
| Form 8-K Indivior Pharmaceuticals For: Jan 23 | SEC filing · Form 8-K | SEC EDGAR | +1.19% | -0.06% | |
| Form S-8 Indivior Pharmaceuticals | SEC filing · Form S-8 | SEC EDGAR | +0.36% | +3.45% | |
| Form S-8 POS Indivior Pharmaceuticals | SEC filing · Form S-8 | SEC EDGAR | +0.36% | +3.45% | |
| Indivior Announces Completion of Redomiciliation to the United States | Press release | GlobeNewswire | +1.19% | -0.06% | |
| Form 8-K INDIVIOR PLC For: Jan 08 | SEC filing · Form 8-K | SEC EDGAR | -1.03% | -3.56% | |
| Indivior Provides Full-Year 2026 Financial Guidance and Business Update | Press release | GlobeNewswire | -1.03% | -3.56% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the INDV section they belong to.
Where else INDV is measured.
INDV earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Indivior PLC's median reaction calculated?
Every labeled INDV news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 938 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 52% of INDV's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does INDV's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.